Patent Assignment
Reel/Frame 019424/0836
Assignment of Assignor's Interest
Recorded: 2007-06-13
Pages: 4
Assignor
VALEANT PHARMACEUTICALS INTERNATIONAL
Executed: 2007-06-06
Assignee
ISIS PHARMACEUTICALS, INC.
1896 RUTHERFORD ROAD, CARLSBAD, CALIFORNIA, 92008
Covered Properties
(3)
Conformationally Constrained L-Nucleosides
Patent:
6,525,191 →
Application:
09/569,183 →
Conformationally constrained L-nucleosides
Application:
10/367,284 →
Publication:
US 2003/0144501
Conformationally Constrained Nucleosides and Oligonucleotides
Application:
60/133,551 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 28, 1999
From: RAMASAMY, KANDASAMY
To: ICN PHARMACEUTICALS, INC.
Reel/Frame 010053/0828 →
Contribution Agreement
Jul 6, 2004
From: ICN PHARMACEUTICALS INC.
To: RIBAPHARM INC.
Reel/Frame 015531/0754 →
Assignment of Assignor's Interest
Jan 21, 2005
From: RAMASAMY, KANDA S
To: RIBAPHARM INC.
Reel/Frame 015589/0504 →
Change of Name
Aug 31, 2005
From: RIBAPHARM INC.
To: VALEANT RESEARCH & DEVELOPMENT
Reel/Frame 016475/0704 →
Merger
Oct 5, 2007
From: ICN PHARMACEUTICALS INC.
To: VALEANT PHARMACEUTICALS INTERNATIONAL
Reel/Frame 019920/0366 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →
Change of Name
Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043349/0673 →